Syneos Health Launches Ventilator Initiative to Raise Awareness of Bridging Option to Address Ventilator Shortage for COVID-19 Patients - Seite 2

“Healthcare systems outside of metropolitan areas may find staff expertise is lacking and will find themselves required to treat outside of their specialty in response to the pandemic,” said Keith Gallagher, FACHE, Vice President, Government and Public Sector at Syneos Health and retired US Army Brigadier General. “This training is vital to support them as they bridge hospital care. We must use every option at our disposal and healthcare providers battling the pandemic must be armed with every bit of practical information and expertise available.”

Skipta, the largest social network of online medical communities, part of Informa Pharma Intelligence, has joined the effort, and will share BiPAP educational materials with their 700,000 strong online healthcare provider social network by launching a new COVID-19 focused physician community platform.

“We recognize the critical need to inform the healthcare professional community of the BiPAP option as a viable solution to deal with ventilator shortages,” said Skipta President, Founder and CEO Theodore Search, PharmD. “Our hope is that by helping to disseminate this information, healthcare professionals will be informed of this option when faced with equipment restraints hindering care.”

“This is an unprecedented time that demands creative solutions, and Syneos Health is committed to contributing in any way we can, including finding innovative ways to help treat those most severely impacted,” said Alistair Macdonald, Chief Executive Officer, Syneos Health. “We applaud the efforts of all of our colleagues and collaborators in this initiative who are raising awareness of this option to help save lives. We hope this effort provides support to those on the frontlines as they deliver care to patients who need it most.”

A white paper, podcast and other education materials are available at www.Covid-BiPAPinfo.com. To join the Skipta network and have access to COVID-19 UNITE, please visit www.skipta.com to find the community relevant to you. 

About Syneos Health
Syneos Health (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Syneos Health brings together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. The Company shares insights, uses the latest technologies, and applies advanced business practices to speed its customers’ delivery of important therapies to patients. To learn more about how Syneos Health is shortening the distance from lab to life, visit syneoshealth.com. For information about Syneos Health’s response, preparedness, resources and perspectives on COVID-19 visit syneoshealth.com/covid-19-resource-center.